Caroline Germa
Chief Tech/Sci/R&D Officer chez TRANSCENTA HOLDING LIMITED
Profil
Caroline Germa is currently the CMO & Executive VP-Global Medicine Development at Transcenta Holding Ltd.
and the Chief Medical Officer at Ikena Oncology, Inc. She previously worked as the Vice President & Head-Early Development Clinical at AstraZeneca PLC.
Dr. Germa holds a doctorate degree from Universite Paris Cite and undergraduate and graduate degrees from Université De Lille.
Postes actifs de Caroline Germa
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 08/08/2022 |
| IKENA ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 29/02/2024 |
Anciens postes connus de Caroline Germa
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 07/08/2022 |
Formation de Caroline Germa
| Universite Paris Cite | Doctorate Degree |
| Université De Lille | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| TRANSCENTA HOLDING LIMITED | Health Technology |
